Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals

Human Immunology

Volumn 71, Issue 2, 2010, Pages 192-194

  Levinson, Ralph D ^a   Okada, Annabelle A ^b   Ashouri, Elham ^c   Keino, Hiroshi ^b   Rajalingam, Raja ^c  

^a JULES STEIN EYE INSTITUTE   (United States)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Disease association; Killer cell immunoglobulin like receptor (KIR); Natural killer (NK) cells; Vogt Koyanagi Harada (VKH) disease

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE CLUSTER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; IMMUNOGENETICS; IMMUNOMODULATION; JAPANESE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; UVEITIS; VOGT KOYANAGI SYNDROME;

ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MULTIGENE FAMILY; RECEPTORS, KIR; SYNDROME; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 74849098817     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.11.001     Document Type: Article

References (30)

1. Rao N.A. Pathology of Vogt-Koyanagi-Harada disease. Int Ophthalmol 27 (2007) 81-85
2. Fang W., and Yang P. Vogt-Koyanagi-Harada syndrome. Curr Eye Res 33 (2008) 517-523
3. Dick A.D., Okada A.A., and Forrester J.V. Practical Manual of Intraocular Inflammation (2008), Informa Healthcare, New York pp 96-100
4. Goto H., Mochizuki M., Yamaki K., Kotake S., Usui M., and Ohno S. Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol 51 (2007) 41-44
5. h1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease. Br J Ophthalmol 80 (1996) 1002-1008
6. + T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. Invest Ophthalmol Vis Sci 47 (2006) 2547-2554
7. Miyazawa I., Abe T., Narikawa K., Feng J., Misu T., Nakashima I., et al. Chemokine profile in the cerebrospinal fluid and serum of Vogt-Koyanagi-Harada disease. J Neuroimmunol 158 (2005) 240-244
8. + CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome. Invest Ophthalmol Vis Sci 49 (2008) 3475-3482
9. + T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol 119 (2007) 1218-1224
10. Liu X., Yang P., Lin X., Ren X., Zhou H., Huang X., et al. Inhibitory effect of cyclosporin A and corticosteroids on the production of IFN-gamma and IL-17 by T cells in Vogt-Koyanagi-Harada syndrome. Clin Immunol 131 (2009) 333-342
11. Shindo Y., Ohno S., Yamamoto T., Nakamura S., and Inoko H. Complete association of the HLA-DRB1*04 and -DQB1* 04 alleles with Vogt-Koyanagi-Harada's disease. Hum Immunol 39 (1994) 169-176
12. Alaez C., del Pilar M.M., Arellanes L., Cano S., Perez-Luque E., Vazquez M.N., et al. Strong association of HLA class II sequences in Mexicans with Vogt-Koyanagi-Harada's disease. Hum Immunol 60 (1999) 875-882
13. Levinson R.D., See R.F., Rajalingam R., Reed E.F., Park M.S., Rao N.A., et al. HLA-DRB1 and -DQB1 alleles in mestizo patients with Vogt-Koyanagi-Harada's disease in Southern California. Hum Immunol 65 (2004) 1477-1482
14. Abad S., Monnet D., Caillat-Zucman S., Mrejen S., Blanche P., Chalumeau M., et al. Characteristics of Vogt-Koyanagi-Harada disease in a French cohort: Ethnicity, systemic manifestations, and HLA genotype data. Ocul Immunol Inflamm 16 (2008) 3-8
15. Khakoo S.I., and Carrington M. KIR and disease: A model system or system of models?. Immunol Rev 214 (2006) 186-201
16. Levinson R.D., Du Z., Luo L., Holland G.N., Rao N.A., Reed E.F., et al. KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. Hum Immunol 69 (2008) 349-353
17. Levinson R.D., Du Z., Luo L., Monnet D., Tabary T., Brezin A.P., et al. Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals. Genes Immun 9 (2008) 249-258
18. Lanier L.L. NK cell recognition. Annu Rev Immunol 23 (2005) 225-274
19. Vilches C., and Parham P. KIR: Diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 20 (2002) 217-251
20. Rajalingam R. Killer cell immunoglobulin-like receptors influence the innate and adaptive immune responses. Iran. J Immunol 4 (2007) 61-78
21. Wilson M.J., Torkar M., Haude A., Milne S., Jones T., Sheer D., et al. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci U S A 97 (2000) 4778-4783
22. Uhrberg M., Valiante N.M., Shum B.P., Shilling H.G., Lienert-Weidenbach K., Corliss B., et al. Human diversity in killer cell inhibitory receptor genes. Immunity 7 (1997) 753-763
23. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5 (2005) 201-214
24. Yawata M., Yawata N., McQueen K.L., Cheng N.W., Guethlein L.A., Rajalingam R., et al. Predominance of group a KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression. Immunogenetics 54 (2002) 543-550
25. Yawata M., Yawata N., Draghi M., Little A.M., Partheniou F., and Parham P. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 203 (2006) 633-645
26. Read R.W., Holland G.N., Rao N.A., Tabbara K.F., Ohno S., Arellanes-Garcia L., et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131 (2001) 647-652
27. Ashouri E., Ghaderi A., Reed E.F., and Rajalingam R. A novel duplex SSP-PCR typing method for KIR gene profiling. Tissue Antigens 74 (2009) 62-67
28. Du Z., Gjertson D.W., Reed E.F., and Rajalingam R. Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans. Immunogenetics 59 (2007) 1-15
29. Du Z., Sharma S.K., Spellman S., Reed E.F., and Rajalingam R. KIR2DL5 alleles mark certain combination of activating KIR genes. Genes Immun 9 (2008) 470-480
30. + T cells in the peripheral blood of uveitis patients. Br J Ophthalmol 83 (1999) 1386-1388